Digestive System Neoplasm
Conditions
Interventions
Experiment group:Kangai injection 40ml 2ivgtt D1-21, combined with the best supportive treatment
Sponsors
Guang’anmen Hospital affiliatied to China Academy of Chinese Medical Sciences
Eligibility
Sex/Gender
All
Age
18 Years to 75 Years
Inclusion criteria
Inclusion criteria: 1. Diagnosis of IV stage digestive system neoplasm according to pathology or cytology; 2. haven't take radiotherapy or chemotherapy, or have finished radiotherapy or chemotherapy treatment for 1 month; 3. KPS score>50; 4. Aged from 18 to 75; 5. Signed informed consent, with good compliance.
Exclusion criteria
Exclusion criteria: 1. Pregnant or lactating women,psychotic patient; 2. Patients with severe,uncontrolled organic lesions or infection, such as decompensated heart, lung, kidney failure can lead to tolerance of chemotherapy; 3. using other antitumor methods or drugs, such as radiotherapytargeted drugsor paticipate in other clinical trials at the same time; 4. patients allergic to the investigational product.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Clinical Symptoms;Quality of Life;QLQ-C30;Adverse Reaction; | — |
Secondary
| Measure | Time frame |
|---|---|
| PFS;RR;DCR;Tumor Marker;Weight;OS; | — |
Countries
China
Contacts
Public ContactHongsheng Lin
Guang'anmen Hospital, China Academy of Chinese Medical Sciences
Outcome results
None listed